Skip to content

Clinical Application Study on the Treatment of Chemotherapy-Induced Nausea and Vomiting with Sanguan Guanyuan Scraping Method Combined with Moxibustion Technology Based on the Theory of Strengthening Healthy Qi

Clinical Application Study on the Treatment of Chemotherapy-Induced Nausea and Vomiting with Sanguan Guanyuan Scraping Method Combined with Moxibustion Technology Based on the Theory of Strengthening Healthy Qi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002005
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

experimental group:Implement the three-point Guan Yuan scraping therapy combined with warm moxibustion technique on the basis of the control group.
control group:Preventive antiemetic medication combined with routine care

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Voluntarily participate in the study and sign the informed consent form; (2) Patients diagnosed with malignant tumors through imaging and/or histopathological or cytological examination; (3) According to the national planning textbook "Integrated Traditional Chinese and Western Medicine Surgery" in higher medical colleges, classified as patients with deficiency of spleen and stomach or deficiency of qi and blood; (4) Chemotherapy regimen is moderately to highly emetogenic or Dranitsaris score = 16 points; (5) Age 18 years or above to 75 years or below, gender not restricted; (6) Expected survival period = 6 months; (7) KPS score = 60 points; (8) Clear consciousness, with independent communication ability, able to read and fill in the questionnaire; (9) Abdominal skin and treatment site skin are intact; non-fasting patients;

Exclusion criteria

Exclusion criteria: (1) Suffering from gastrointestinal bleeding, infection in other parts or organs, or being in the advanced stage of the disease and unable to tolerate treatment; (2) Complicated with severe primary diseases such as cardiovascular, liver, kidney, hematopoietic system diseases; (3) Presenting with obvious abnormal coagulation function, thrombocytopenia or bleeding disorders; (4) In the bleeding stage of peptic ulcer disease, within half a year after bleeding, or having a history of gastrointestinal perforation, liver cirrhosis ascites, hematochezia, hematuria, etc.; (5) Complicated with other diseases causing nausea and vomiting symptoms, such as Meniere's syndrome, symptomatic brain metastasis, etc.; (6) Experienced severe nausea and vomiting for no apparent reason within 24 hours before the intervention; (7) Pregnant or lactating women; (8) Unable to tolerate the related operations of traditional Chinese medicine nursing, with relevant allergy history; (9) Having previous or current mental disorders, intellectual disabilities, language communication disorders, and difficulty in judging the intensity of pain; (10) Participating in any other clinical studies for preventing or treating nausea and vomiting during chemotherapy.

Design outcomes

Primary

MeasureTime frame
Effective rate of vomiting treatment;

Secondary

MeasureTime frame
Traditional Chinese Medicine Symptom Score;MASCC Antiemesis Evaluation Tool;

Countries

CHINA

Contacts

Public ContactShen Yonghong

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

962598504@qq.com18229826469

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026